FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 141 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,967,000 | +104.0% | 700,100 | -29.5% | 0.02% | +150.0% |
Q2 2022 | $6,847,000 | +15.0% | 993,732 | +55.2% | 0.01% | +14.3% |
Q1 2022 | $5,954,000 | +23.9% | 640,200 | +89.5% | 0.01% | +16.7% |
Q4 2021 | $4,805,000 | +153.0% | 337,900 | +312.6% | 0.01% | +200.0% |
Q3 2021 | $1,899,000 | – | 81,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |